Lexaria Bioscience Corp (LEXX)
2.16
-0.04
(-1.82%)
USD |
NASDAQ |
Nov 21, 16:00
2.17
+0.01
(+0.46%)
Pre-Market: 20:00
Lexaria Bioscience Market Cap: 34.15M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 34.15M |
| November 20, 2024 | 34.78M |
| November 19, 2024 | 34.31M |
| November 18, 2024 | 33.04M |
| November 15, 2024 | 31.78M |
| November 14, 2024 | 33.52M |
| November 13, 2024 | 35.73M |
| November 12, 2024 | 36.36M |
| November 11, 2024 | 36.52M |
| November 08, 2024 | 37.31M |
| November 07, 2024 | 36.68M |
| November 06, 2024 | 34.62M |
| November 05, 2024 | 35.26M |
| November 04, 2024 | 36.05M |
| November 01, 2024 | 36.68M |
| October 31, 2024 | 33.99M |
| October 30, 2024 | 35.89M |
| October 29, 2024 | 37.31M |
| October 28, 2024 | 39.84M |
| October 25, 2024 | 41.90M |
| October 24, 2024 | 43.16M |
| October 23, 2024 | 42.69M |
| October 22, 2024 | 43.64M |
| October 21, 2024 | 43.48M |
| October 18, 2024 | 43.64M |
| Date | Value |
|---|---|
| October 17, 2024 | 44.74M |
| October 16, 2024 | 45.38M |
| October 15, 2024 | 45.38M |
| October 14, 2024 | 48.38M |
| October 11, 2024 | 49.01M |
| October 10, 2024 | 48.38M |
| October 09, 2024 | 47.04M |
| October 08, 2024 | 48.38M |
| October 07, 2024 | 48.85M |
| October 04, 2024 | 50.43M |
| October 03, 2024 | 52.33M |
| October 02, 2024 | 52.17M |
| October 01, 2024 | 49.96M |
| September 30, 2024 | 48.22M |
| September 27, 2024 | 47.75M |
| September 26, 2024 | 46.96M |
| September 25, 2024 | 49.33M |
| September 24, 2024 | 49.33M |
| September 23, 2024 | 49.96M |
| September 20, 2024 | 51.54M |
| September 19, 2024 | 49.80M |
| September 18, 2024 | 50.91M |
| September 17, 2024 | 51.54M |
| September 16, 2024 | 53.28M |
| September 13, 2024 | 54.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.639M
Minimum
May 10 2023
77.42M
Maximum
Mar 11 2024
25.69M
Average
24.30M
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 1.256B |
| Edesa Biotech Inc | 6.852M |
| Xenon Pharmaceuticals Inc | 3.034B |
| ESSA Pharma Inc | 78.09M |
| ImmunoPrecise Antibodies Ltd | 9.726M |
Market Cap Related Metrics
| PS Ratio | 54.89 |
| Price to Book Value | 3.374 |
| Price | 2.16 |
| Earnings Yield | -20.37% |